Article Information
History
- July 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ebene R Haycroft1,*,
- Samantha K Davis1,*,
- Pradhipa Ramanathan1,
- Ester Lopez1,
- Ruth A Purcell1,
- Li Lynn Tan2,7,
- Phillip Pymm2,
- Bruce D Wines3,4,5,
- P Mark Hogarth3,4,5,
- Adam K Wheatley1,
- Jennifer A. Juno1,
- Samuel Redmond1,
- Nicholas A Gheradin1,
- Dale I Godfrey1,6,
- Wai-Hong Tham2,7,
- Kevin John Selva1,#,*,
- Stephen J Kent1,8,#,* and
- Amy W Chung1,#,*
- 1Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria.
- 2The Walter and Eliza Hall Institute of Medical Research, Parkville, Melbourne, Victoria.
- 3Immune Therapies Group, Burnet Institute, Melbourne, Victoria.
- 4Department of Clinical Pathology, University of Melbourne, Melbourne, Victoria.
- 5Department of Immunology and Pathology, Central Clinical School, Monash University, Melbourne, Victoria.
- 6Australian Research Council Centre of Excellence for Advanced Molecular Imaging, University of Melbourne, Melbourne, Victoria.
- 7Department of Medical Biology, University of Melbourne, Melbourne, Victoria.
- 8Melbourne Sexual Health Centre, Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Victoria.
- ↵#Correspondence: Amy W Chung awchung{at}unimelb.edu.au Stephen J Kent skent{at}unimelb.edu.au Kevin John Selva kevin.selva{at}unimelb.edu.au Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Victoria 3000, Australia
↵* Equally contributed
Posted July 10, 2022.
Altered affinity to ACE2 and reduced Fc functional antibodies to SARS-CoV-2 RBD variants
